Overview

A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if ALRT1057 gel is safe and effective in treating Kaposi's sarcoma (KS) when applied to skin .
Phase:
N/A
Details
Lead Sponsor:
Anderson Clinical Research
Collaborator:
Ligand Pharmaceuticals
Treatments:
Alitretinoin